Compare BLLN & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLLN | PJT |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.4B |
| IPO Year | 2025 | 2015 |
| Metric | BLLN | PJT |
|---|---|---|
| Price | $93.00 | $181.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $126.71 | ★ $178.50 |
| AVG Volume (30 Days) | ★ 797.8K | 358.2K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | ★ 103.40 | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | $305,112,000.00 | ★ $1,713,671,000.00 |
| Revenue This Year | $46.29 | $11.12 |
| Revenue Next Year | $30.14 | $9.98 |
| P/E Ratio | $198.23 | ★ $23.03 |
| Revenue Growth | ★ 99.97 | 14.77 |
| 52 Week Low | $61.96 | $127.73 |
| 52 Week High | $150.44 | $195.62 |
| Indicator | BLLN | PJT |
|---|---|---|
| Relative Strength Index (RSI) | 39.93 | 61.05 |
| Support Level | $88.38 | $166.43 |
| Resistance Level | $95.82 | $195.62 |
| Average True Range (ATR) | 4.51 | 5.25 |
| MACD | 0.13 | 0.26 |
| Stochastic Oscillator | 47.48 | 93.43 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services, and others. Geographically, it generates maximum revenue from the United States, followed by the United Kingdom and other markets.